December 7, 2017 — Edwards Lifesciences Corp. announced the acquisition of Harpoon Medical Inc., a privately held ...
Toshiba Medical, a Canon Group company, showcased the Aquilion Precision, what it calls the world’s first ultra-high resolution computed tomography system (UHR CT) at the 2017 Radiological Society of North America (RSNA) Annual Meeting, Nov. 26-Dec. 1 in Chicago. The system, which is pending U.S. Food and Drug Administration (FDA) 510(k) clearance, is capable of resolving anatomy as small as 150 microns, providing CT image quality with resolution typically seen only in cath labs. The UHR detector is newly designed to provide more than twice the resolution when compared with today’s CT technology, featuring an all-new detector as well as tube, gantry and reconstruction technologies.
December 6, 2017 — French company Robocath, which designs and develops robotic solutions for the treatment of vascular ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine ...
December 6, 2017 — At the American Heart Association (AHA) annual meeting in November, a group of 16 non-partisan ...
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 6, 2017 — Women who develop high blood pressure during pregnancy are more likely to experience heart problems ...
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health ...
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery works significantly better than traditional risk assessment tools, according to new research from the University of California Los Angeles (UCLA). By having more accurate information, older patients and their physicians can make an informed decision on whether to undergo surgery, UCLA researchers concluded.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Infant deaths from critical congenital heart disease (CCHD) decreased more than 33 percent in eight states that mandated screening for CCHD using a test called pulse oximetry. In addition, deaths from other or unspecified cardiac causes decreased by 21 percent, according to a recent study.
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen Edition 1.5T, to deliver comfortable, effortless and efficient exams in healthcare facilities of all sizes. The Zen Edition prioritizes intelligent workflow and patient comfort, providing clinical applications to help providers make accurate diagnoses.
Fujifilm Medical Systems U.S.A. Inc. announced the expansion of the company's artificial intelligence (AI) development initiative with entry in the U.S. market. The AI development initiative will harness the power of AI to enhance Fujifilm’s imaging and informatics healthcare Synapse portfolio which includes Synapse PACS (picture archiving and communication system), Synapse Cardiovascular and Synapse VNA (vendor neutral archive), among other solutions. The initiative was on display at the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec. 1 in Chicago.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Toshiba Medical, a Canon Group company, introduced new educational tools and interactive learning resources to help healthcare providers stay current on CMEs and clinical education without impacting busy schedules. The new advancements give clinicians more accessible and mobile-friendly resources and accreditation opportunities that fit into their on-the-go schedules.
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical workflow benefits of its next-generation image-guided therapy platform, Azurion. The study investigated nearly 800 patient procedures to evaluate the impact of Azurion at St. Antonius Hospital in Nieuwegein, the Netherlands. The data demonstrated clinicians’ use of Azurion resulted in significant time savings for the hospital, including a 17 percent reduction of the average interventional procedure time, a 12 percent reduction of in-lab patient preparation time, and a 28 percent reduction of post-procedure lab time.
December 4, 2017 — Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone ...